Amphastar Pharmaceuticals, Inc.
AMPH
$22.97
$0.040.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 78.55M | 79.23M | 98.09M | 111.63M | 134.71M |
| Total Depreciation and Amortization | 64.71M | 64.49M | 63.20M | 61.88M | 60.54M |
| Total Amortization of Deferred Charges | 3.39M | 3.35M | 3.36M | 3.21M | 3.07M |
| Total Other Non-Cash Items | 55.98M | 55.76M | 57.44M | 7.39M | 12.49M |
| Change in Net Operating Assets | -18.01M | -33.95M | -65.97M | -31.83M | -51.16M |
| Cash from Operations | 184.61M | 168.88M | 156.12M | 152.28M | 159.66M |
| Capital Expenditure | -31.72M | -33.69M | -34.88M | -39.02M | -47.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.33M | -63.85M | -35.45M | -6.42M | -12.94M |
| Cash from Investing | -52.05M | -97.55M | -70.33M | -45.44M | -60.41M |
| Total Debt Issued | 445.00K | 4.57M | 6.22M | 10.81M | 20.15M |
| Total Debt Repaid | -702.00K | -214.00K | -223.00K | -234.00K | -231.00K |
| Issuance of Common Stock | 3.88M | 2.86M | 2.86M | 873.00K | 494.00K |
| Repurchase of Common Stock | -100.07M | -90.08M | -75.59M | -93.69M | -120.53M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.00K | -265.00K | -687.00K | -657.00K | -1.24M |
| Cash from Financing | -96.46M | -83.13M | -67.43M | -82.89M | -101.36M |
| Foreign Exchange rate Adjustments | -172.00K | -46.00K | 210.00K | 208.00K | 186.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.93M | -11.84M | 18.57M | 24.15M | -1.93M |